Epigenetic regulation of cancer stem cells in liver cancer: Current concepts and clinical implications

Journal of Hepatology

Volumn 53, Issue 3, 2010, Pages 568-577

  Marquardt, J U ^a   Factor, V M ^a   Thorgeirsson, S S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer stem cells; Epigenetics; Liver cancer; Side population

Indexed keywords

ALDEHYDE DEHYDROGENASE; BETA CATENIN; BIOLOGICAL MARKER; CD133 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; KRUPPEL LIKE FACTOR 4; MYC PROTEIN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; SONIC HEDGEHOG PROTEIN; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

CANCER RELAPSE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL RENEWAL; CLONAL VARIATION; DISTANT METASTASIS; EARLY DIAGNOSIS; EPIGENETICS; GERMINAL CENTER; HUMAN; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SOLID TUMOR; STOCHASTIC MODEL;

ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, NEOPLASM; ANTIGENS, THY-1; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL DIVISION; CELL SEPARATION; EPIGENESIS, GENETIC; GENES, MYC; GLYCOPROTEINS; HEDGEHOG PROTEINS; HUMANS; LIVER NEOPLASMS; MICRORNAS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PEPTIDES; PROTO-ONCOGENE PROTEINS; RECEPTORS, NOTCH; REPRESSOR PROTEINS; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS;

EID: 77955852219     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.05.003     Document Type: Review

References (162)

1. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
2. P.C. Nowell Clonal Evolution of Tumor-Cell Populations Science 194 1976 23 28
3. D.E. Bergsagel, and F.A. Valeriote Growth characteristics of a mouse plasma cell tumor Cancer Res 28 1968 2187 2196
4. G.H. Heppner Tumor heterogeneity Cancer Res 44 1984 2259 2265
5. L.M. Weisenthal, and M.E. Lippman Clonogenic and nonclonogenic in vitro chemosensitivity assays Cancer Treat Rep 69 1985 615 632
6. H.B. Hewitt Studies of the dissemination and quantitative transplantation of a lymphocytic leukaemia of CBA mice Br J Cancer 12 1958 378 401
7. C.M. Southam, and A. Brunschwig Quantitative studies of autotransplantation of human cancer - preliminary report Cancer 14 1961 971
8. A.W. Hamburger, and S.E. Salmon Primary bioassay of human tumor stem cells Science 197 1977 461 463
9. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
10. L.L. Campbell, and K. Polyak Breast tumor heterogeneity: cancer stem cells or clonal evolution? Cell Cycle 6 2007 2332 2338 (Pubitemid 350058682)
11. M.F. Clarke, J.E. Dick, P.B. Dirks, C.J. Eaves, C.H. Jamieson, and D.L. Jones Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339 9344
12. C.T. Jordan, M.L. Guzman, and M. Noble Cancer stem cells N Engl J Med 355 2006 1253 1261
13. M.R. Alison Liver stem cells: implications for hepatocarcinogenesis Stem Cell Rev 1 2005 253 260
14. J.U. Marquardt, and S.S. Thorgeirsson Stem cells in hepatocarcinogenesis: evidence from genomic data Semin Liver Dis 30 2010 26 34
15. L. Mishra, T. Banker, J. Murray, S. Byers, A. Thenappan, and A.R. He Liver stem cells and hepatocellular carcinoma Hepatology 49 2009 318 329
16. M. Kakarala, and M.S. Wicha Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy J Clin Oncol 26 2008 2813 2820
17. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
18. J.M. Llovet, and J. Bruix Molecular targeted therapies in hepatocellular carcinoma Hepatology 48 2008 1312 1327
19. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
20. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nat Rev Cancer 6 2006 674 687
21. R. Ganguly, and I.K. Puri Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis Cell Prolif 40 2007 338 354
22. G. Zajicek Resistance to cancer chemotherapy Med Hypotheses 19 1986 103 112
23. K. Polyak, and R.A. Weinberg Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer 9 2009 265 273
24. C.Y. Park, D. Tseng, and I.L. Weissman Cancer stem cell-directed therapies: recent data from the laboratory and clinic Mol Ther 17 2009 219 230
25. S. Ma, K.W. Chan, L. Hu, T.K. Lee, J.Y. Wo, and I.O. Ng Identification and characterization of tumorigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
26. C.B. Rountree, S. Senadheera, J.M. Mato, G.M. Crooks, and S.C. Lu Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice Hepatology 47 2008 1288 1297
27. A. Suetsugu, M. Nagaki, H. Aoki, T. Motohashi, T. Kunisada, and H. Moriwaki Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells Biochem Biophys Res Commun 351 2006 820 824
28. S. Ma, T.K. Lee, B.J. Zheng, K.W. Chan, and X.Y. Guan CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway Oncogene 27 2008 1749 1758
29. C.B. Rountree, W. Ding, L. He, and B. Stiles Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice Stem cells 27 2009 290 299
30. Z.F. Yang, D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, and P. Ngai Significance of CD90+ cancer stem cells in human liver cancer Cancer Cell 13 2008 153 166
31. Z.F. Yang, P. Ngai, D.W. Ho, W.C. Yu, M.N. Ng, and C.K. Lau Identification of local and circulating cancer stem cells in human liver cancer Hepatology 47 2008 919 928 (Pubitemid 351449683)
32. M. Munz, P.A. Baeuerle, and O. Gires The emerging role of EpCAM in cancer and stem cell signaling Cancer Res 69 2009 5627 5629
33. S.V. Shmelkov, J.M. Butler, A.T. Hooper, A. Hormigo, J. Kushner, and T. Milde CD133 expression is not restricted to stem cells, and both CD133+ and C J Clin Invest 118 2008 2111 2120
34. T. Yamashita, J. Ji, A. Budhu, M. Forgues, W. Yang, and H.Y. Wang EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
35. M. Al-Hajj, M.S. Wicha, A. ito-Hernandez, S.J. Morrison, and M.F. Clarke Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100 2003 3983 3988 (Pubitemid 36418143)
36. L. Ricci-Vitiani, D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, and C. Peschle Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111 115
37. C. Li, D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, and V. Adsay Identification of pancreatic cancer stem cells Cancer Res 67 2007 1030 1037
38. T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, and H. Jia EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
39. M.A. Goodell, K. Brose, G. Paradis, A.S. Conner, and R.C. Mulligan Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo J Exp Med 183 1996 1797 1806
40. G.M. Shi, Y. Xu, J. Fan, J. Zhou, X.R. Yang, and S.J. Qiu Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials J Cancer Res Clin Oncol 134 2008 1155 1163
41. N. Haraguchi, T. Utsunomiya, H. Inoue, F. Tanaka, K. Mimori, and G.F. Barnard Characterization of a side population of cancer cells from human gastrointestinal system Stem Cells 24 2006 506 513
42. T. Chiba, K. Kita, Y.W. Zheng, O. Yokosuka, H. Saisho, and A. Iwama Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties Hepatology 44 2006 240 251
43. T. Chiba, S. Miyagi, A. Saraya, R. Aoki, A. Seki, and Y. Morita The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma Cancer Res 68 2008 7742 7749
44. S. Ma, K.W. Chan, T.K. Lee, K.H. Tang, J.Y. Wo, and B.J. Zheng Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations Mol Cancer Res 6 2008 1146 1153
45. C.A. Gilbert, and A.H. Ross Cancer stem cells: cell culture, markers, and targets for new therapies J Cell Biochem 108 2009 1031 1038
46. H. Fujii, K. Honoki, T. Tsujiuchi, A. Kido, K. Yoshitani, and Y. Takakura Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines Int J Oncol 34 2009 1381 1386
47. S. Pece, D. Tosoni, S. Confalonieri, G. Mazzarol, M. Vecchi, and S. Ronzoni Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content Cell 140 2010 62 73
48. J.E. Visvader, and G.J. Lindeman Cancer stem cells in solid tumours: accumulating evidence and unresolved questions Nat Rev Cancer 8 2008 755 768
49. S.R. Pine, B.M. Ryan, L. Varticovski, A.I. Robles, and C.C. Harris Microenvironmental modulation of asymmetric cell division in human lung cancer cells Proc Natl Acad Sci USA 107 2010 2195 2200
50. F.L. Kiechle, and X. Zhang Apoptosis: biochemical aspects and clinical implications Clin Chim Acta 326 2002 27 45
51. D.C. Taussig, F. Miraki-Moud, F. njos-Afonso, D.J. Pearce, K. Allen, and C. Ridler Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells Blood 112 2008 568 575
52. A.J. Potgens, U. Schmitz, P. Kaufmann, and H.G. Frank Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18 J Histochem Cytochem 50 2002 1131 1134
53. T. Baba, P.A. Convery, N. Matsumura, R.S. Whitaker, E. Kondoh, and T. Perry Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells Oncogene 28 2009 209 218
54. K. Tabu, K. Sasai, T. Kimura, L. Wang, E. Aoyanagi, and S. Kohsaka Promoter hypomethylation regulates CD133 expression in human gliomas Cell Res 18 2008 1037 1046
55. S. Bidlingmaier, X. Zhu, and B. Liu The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells J Mol Med 86 2008 1025 1032
56. C.E. Griguer, C.R. Oliva, E. Gobin, P. Marcorelles, D.J. Benos, and J.R. Lancaster Jr. CD133 is a marker of bioenergetic stress in human glioma PLoS ONE 3 2008 e3655
57. S.M. Pollard, K. Yoshikawa, I.D. Clarke, D. Danovi, S. Stricker, and R. Russell Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens Cell Stem Cell 4 2009 568 580
58. K. Woolard, and H.A. Fine Glioma stem cells: better flat than round Cell Stem Cell 4 2009 466 467
59. P.N. Kelly, A. Dakic, J.M. Adams, S.L. Nutt, and A. Strasser Tumor growth need not be driven by rare cancer stem cells Science 317 2007 337
60. R.P. Hill Identifying cancer stem cells in solid tumors: case not proven Cancer Res 66 2006 1891 1895
61. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 2009 822 829
62. E. Charafe-Jauffret, C. Ginestier, F. Iovino, J. Wicinski, N. Cervera, and P. Finetti Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69 2009 1302 1313
63. T. Kondo, T. Setoguchi, and T. Taga Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line Proc Natl Acad Sci USA 101 2004 781 786
64. J.S. Lee, and S.S. Thorgeirsson Genetic profiling of human hepatocellular carcinoma Semin Liver Dis 25 2005 125 132
65. N. Iizuka, M. Oka, H. Yamada-Okabe, M. Nishida, Y. Maeda, and N. Mori Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection Lancet 361 2003 923 929
66. J.S. Lee, I.S. Chu, J. Heo, D.F. Calvisi, Z. Sun, and T. Roskams Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676 (Pubitemid 39265589)
67. Q.H. Ye, L.X. Qin, M. Forgues, P. He, J.W. Kim, and A.C. Peng Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning Nat Med 9 2003 416 423
68. A. Villanueva, P. Newell, D.Y. Chiang, S.L. Friedman, and J.M. Llovet Genomics and signaling pathways in hepatocellular carcinoma Semin Liver Dis 27 2007 55 76
69. A.W. Duncan, C. Dorrell, and M. Grompe Stem cells and liver regeneration Gastroenterology 137 2009 466 481
70. E. Santoni-Rugiu, P. Jelnes, S.S. Thorgeirsson, and H.C. Bisgaard Progenitor cells in liver regeneration: molecular responses controlling their activation and expansion APMIS 113 2005 876 902
71. W. Yang, H.X. Yan, L. Chen, Q. Liu, Y.Q. He, and L.X. Yu Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells Cancer Res 68 2008 4287 4295
72. Y. Hoshida, S.M. Nijman, M. Kobayashi, J.A. Chan, J.P. Brunet, and D.Y. Chiang Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
73. J.S. Lee, I.S. Chu, A. Mikaelyan, D.F. Calvisi, J. Heo, and J.K. Reddy Application of comparative functional genomics to identify best-fit mouse models to study human cancer Nat Genet 36 2004 1306 1311
74. C.M. Shachaf, A.M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, and S. Mandl MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer Nature 431 2004 1112 1117
75. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
76. J.S. Lee, and S.S. Thorgeirsson Comparative and integrative functional genomics of HCC Oncogene 25 2006 3801 3809
77. R.T. Moon, A.D. Kohn, G.V. De Ferrari, and A. Kaykas WNT and beta-catenin signalling: diseases and therapies Nat Rev Genet 5 2004 691 701
78. K.S. Zaret Genetic programming of liver and pancreas progenitors: lessons for stem-cell differentiation Nat Rev Genet 9 2008 329 340
79. N. Barker, and H. Clevers Mining the Wnt pathway for cancer therapeutics Nat Rev Drug Discov 5 2006 997 1014
80. S. Boyault, D.S. Rickman, R.A. de, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
81. J. Espada, M.B. Calvo, S. az-Prado, and V. Medina Wnt signalling and cancer stem cells Clin Transl Oncol 11 2009 411 427
82. Y. Teng, X. Wang, Y. Wang, and D. Ma Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells Biochem Biophys Res Commun 392 2010 373 379
83. N. Janssens, M. Janicot, and T. Perera The Wnt-dependent signaling pathways as target in oncology drug discovery Invest New Drugs 24 2006 263 280
84. J. Gearhart, E.E. Pashos, and M.K. Prasad Pluripotency redux-advances in stem-cell research N Engl J Med 357 2007 1469 1472
85. R. Sridharan, J. Tchieu, M.J. Mason, R. Yachechko, E. Kuoy, and S. Horvath Role of the murine reprogramming factors in the induction of pluripotency Cell 136 2009 364 377
86. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
87. L. Soucek, J. Whitfield, C.P. Martins, A.J. Finch, D.J. Murphy, and N.M. Sodir Modelling Myc inhibition as a cancer therapy Nature 455 2008 679 683
88. P. Kaposi-Novak, L. Libbrecht, H.G. Woo, Y.H. Lee, N.C. Sears, and E.A. Conner Central role of c-Myc during malignant conversion in human hepatocarcinogenesis Cancer Res 69 2009 2775 2782
89. R.T. Sussman, M.S. Ricci, L.S. Hart, S.Y. Sun, and W.S. El-Deiry Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4 Cancer Biol Ther 6 2007 1490 1495
90. J. Wang, H. Wang, Z. Li, Q. Wu, J.D. Lathia, and R.E. McLendon C-Myc is required for maintenance of glioma cancer stem cells PLoS ONE 3 2008 e3769
91. D.J. Murphy, M.R. Junttila, L. Pouyet, A. Karnezis, K. Shchors, and D.A. Bui Distinct thresholds govern Myc's biological output in vivo Cancer Cell 14 2008 447 457
92. L. Mishra, R. Derynck, and B. Mishra Transforming growth factor-beta signaling in stem cells and cancer Science 310 2005 68 71
93. C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067
94. R. Amin, and L. Mishra Liver stem cells and tgf-Beta in hepatic carcinogenesis Gastrointest Cancer Res 2 2008 S27 S30
95. Y. Tang, K. Kitisin, W. Jogunoori, C. Li, C.X. Deng, and S.C. Mueller Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling Proc Natl Acad Sci USA 105 2008 2445 2450
96. L. Lin, R. Amin, G.I. Gallicano, E. Glasgow, W. Jogunoori, and J.M. Jessup The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling Oncogene 28 2009 961 972
97. V. Bolos, J. Grego-Bessa, and J.L. de la Pompa Notch signaling in development and cancer Endocr Rev 28 2007 339 363
98. Y. Zong, A. Panikkar, J. Xu, A. Antoniou, P. Raynaud, and F. Lemaigre Notch signaling controls liver development by regulating biliary differentiation Development 136 2009 1727 1739
99. J. Gao, Z. Song, Y. Chen, L. Xia, J. Wang, and R. Fan Deregulated expression of Notch receptors in human hepatocellular carcinoma Dig Liver Dis 40 2008 114 121
100. V. Bolos, M. Blanco, V. Medina, G. Aparicio, S. az-Prado, and E. Grande Notch signalling in cancer stem cells Clin Transl Oncol 11 2009 11 19
101. L. Miele, H. Miao, and B.J. Nickoloff NOTCH signaling as a novel cancer therapeutic target Curr Cancer Drug Targets 6 2006 313 323
102. C. Osipo, and L. Miele Hedgehog signaling in hepatocellular carcinoma: novel therapeutic strategy targeting hedgehog signaling in HCC Cancer Biol Ther 5 2006 238 239
103. L. Yang, G. Xie, Q. Fan, and J. Xie Activation of the hedgehog-signaling pathway in human cancer and the clinical implications Oncogene 29 2010 469 481
104. K. Quint, S. Stintzing, B. Alinger, C. Hauser-Kronberger, O. Dietze, and S. Gahr The expression pattern of PDX-1, SHH, Patched and Gli-1 is associated with pathological and clinical features in human pancreatic cancer Pancreatology 9 2009 116 126
105. I.K. Park, D. Qian, M. Kiel, M.W. Becker, M. Pihalja, and I.L. Weissman Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells Nature 423 2003 302 305
106. M.E. Valk-Lingbeek, S.W. Bruggeman, and L.M. Van Stem cells and cancer; the polycomb connection Cell 118 2004 409 418
107. C. Leung, M. Lingbeek, O. Shakhova, J. Liu, E. Tanger, and P. Saremaslani Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas Nature 428 2004 337 341
108. M. Sasaki, H. Ikeda, K. Itatsu, J. Yamaguchi, S. Sawada, and H. Minato The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma Lab Invest 88 2008 873 882
109. T. Chiba, Y.W. Zheng, K. Kita, O. Yokosuka, H. Saisho, and M. Onodera Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation Gastroenterology 133 2007 937 950
110. A.P. Feinberg, and B. Tycko The history of cancer epigenetics Nat Rev Cancer 4 2004 143 153
111. A.P. Feinberg Phenotypic plasticity and the epigenetics of human disease Nature 447 2007 433 440
112. A.P. Feinberg, R. Ohlsson, and S. Henikoff The epigenetic progenitor origin of human cancer Nat Rev Genet 7 2006 21 33
113. A.M. Broske, L. Vockentanz, S. Kharazi, M.R. Huska, E. Mancini, and M. Scheller DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction Nat Genet 41 2009 1207 1215
114. M. Widschwendter, H. Fiegl, D. Egle, E. Mueller-Holzner, G. Spizzo, and C. Marth Epigenetic stem cell signature in cancer Nat Genet 39 2007 157 158
115. R.A. Irizarry, C. Ladd-Acosta, B. Wen, Z. Wu, C. Montano, and P. Onyango The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores Nat Genet 41 2009 178 186
116. S. Lee, H.J. Lee, J.H. Kim, H.S. Lee, J.J. Jang, and G.H. Kang Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis Am J Pathol 163 2003 1371 1378 (Pubitemid 37175085)
117. D.F. Calvisi, S. Ladu, A. Gorden, M. Farina, J.S. Lee, and E.A. Conner Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma J Clin Invest 117 2007 2713 2722
118. Marquardt JU, Raggi C, Andersen JB, Seo D, Avital I, Holczbauer A, et al. Gene expression signature of putative Cancer Stem Cells predicts survival of HCC patients., Abstract: 1182, AASLD meeting 2009, Boston, MA, USA ed 2009.
119. A. Ventura, and T. Jacks MicroRNAs and cancer: short RNAs go a long way Cell 136 2009 586 591
120. C. Coulouarn, V.M. Factor, J.B. Andersen, M.E. Durkin, and S.S. Thorgeirsson Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties Oncogene 28 2009 3526 3536
121. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
122. P. Pineau, S. Volinia, K. McJunkin, A. Marchio, C. Battiston, and B. Terris MiR-221 overexpression contributes to liver tumorigenesis Proc Natl Acad Sci USA 107 2010 264 269
123. Q.W. Wong, R.W. Lung, P.T. Law, P.B. Lai, K.Y. Chan, and K.F. To MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 2008 257 269
124. Q.W. Wong, A.K. Ching, A.W. Chan, K.W. Choy, K.F. To, and P.B. Lai MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling Clin Cancer Res 16 2010 867 875
125. P.B. Dirks MicroRNAs and parallel stem cell lives Cell 138 2009 423 424
126. Y. Shimono, M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, and D. Qian Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 2009 592 603
127. J.T. DeSano, and L. Xu MicroRNA regulation of cancer stem cells and therapeutic implications AAPS J 11 2009 682 692
128. M.E. Peter Regulating cancer stem cells the miR way Cell Stem Cell 6 2010 4 6
129. J. Ji, T. Yamashita, A. Budhu, M. Forgues, H.L. Jia, and C. Li Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells Hepatology 50 2009 472 480
130. M. Schoenhals, A. Kassambara, V.J. De, D. Hose, J. Moreaux, and B. Klein Embryonic stem cell markers expression in cancers Biochem Biophys Res Commun 383 2009 157 162
131. C.R. Jeter, M. Badeaux, G. Choy, D. Chandra, L. Patrawala, and C. Liu Functional evidence that the self-renewal gene NANOG regulates human tumor development Stem Cells 27 2009 993 1005
132. E. Segal, N. Friedman, D. Koller, and A. Regev A module map showing conditional activity of expression modules in cancer Nat Genet 36 2004 1090 1098
133. D.J. Wong, H. Liu, T.W. Ridky, D. Cassarino, E. Segal, and H.Y. Chang Module map of stem cell genes guides creation of epithelial cancer stem cells Cell Stem Cell 2 2008 333 344
134. I. Ben-Porath, M.W. Thomson, V.J. Carey, R. Ge, G.W. Bell, and A. Regev An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors Nat Genet 40 2008 499 507
135. D.X. Nguyen, P.D. Bos, and J. Massague Metastasis: from dissemination to organ-specific colonization Nat Rev Cancer 9 2009 274 284
136. M.Y. Kim, T. Oskarsson, S. Acharyya, D.X. Nguyen, X.H. Zhang, and L. Norton Tumor self-seeding by circulating cancer cells Cell 139 2009 1315 1326
137. L. Li, and W.B. Neaves Normal stem cells and cancer stem cells: the niche matters Cancer Res 66 2006 4553 4557
138. M.J. Bissell, and M.A. Labarge Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell 7 2005 17 23
139. S. Jaiswal, C.H. Jamieson, W.W. Pang, C.Y. Park, M.P. Chao, and R. Majeti CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis Cell 138 2009 271 285
140. J. Lu, T. Fan, Q. Zhao, W. Zeng, E. Zaslavsky, and J.J. Chen Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients Int J Cancer 126 2010 669 683
141. J.B. Ahn, S.Y. Rha, S.J. Shin, H.C. Jeung, T.S. Kim, and X. Zhang Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients Cancer Lett 288 2009 124 132
142. P.C. Hermann, S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, and M. Guba Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1 2007 313 323
143. B. Aktas, M. Tewes, T. Fehm, S. Hauch, R. Kimmig, and S. Kasimir-Bauer Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients Breast Cancer Res 11 2009 R46
144. R. Liu, X. Wang, G.Y. Chen, P. Dalerba, A. Gurney, and T. Hoey The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356 2007 217 226
145. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
146. J.M. Llovet, M. Schwartz, and V. Mazzaferro Resection and liver transplantation for hepatocellular carcinoma Semin Liver Dis 25 2005 181 200
147. M.A. Zimmerman, R.M. Ghobrial, M.J. Tong, J.R. Hiatt, A.M. Cameron, and J. Hong Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators Arch Surg 143 2008 182 188
148. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917
149. R.J. Gilbertson, and J.N. Rich Making a tumour's bed: glioblastoma stem cells and the vascular niche Nat Rev Cancer 7 2007 733 736
150. M.B. Meads, L.A. Hazlehurst, and W.S. Dalton The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance Clin Cancer Res 14 2008 2519 2526
151. Y. Gokmen-Polar, and K.D. Miller Redefining the target again: chemotherapeutics as vascular disrupting agents? Cancer Cell 14 2008 195 196
152. Y. Endo, K. Deonauth, P. Prahalad, B. Hoxter, Y. Zhu, and S.W. Byers Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells PLoS ONE 3 2008 e2714
153. T.G. Nishanian, J.S. Kim, A. Foxworth, and T. Waldman Suppression of tumorigenesis and activation of Wnt signaling by bone morphogenetic protein 4 in human cancer cells Cancer Biol Ther 3 2004 667 675
154. H. Zhao, O. Ayrault, F. Zindy, J.H. Kim, and M.F. Roussel Post-transcriptional down-regulation of Atoh1/Math1 by bone morphogenic proteins suppresses medulloblastoma development Genes Dev 22 2008 722 727
155. P.B. Gupta, T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, and R.A. Weinberg Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening Cell 138 2009 645 659
156. C. Yin, Y. Lin, X. Zhang, Y.X. Chen, X. Zeng, and H.Y. Yue Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene Hepatology 48 2008 1528 1539
157. A.V. Salnikov, G. Kusumawidjaja, V. Rausch, H. Bruns, W. Gross, and A. Khamidjanov Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter Cancer Lett 275 2009 185 193
158. R. Artells, I. Moreno, T. Diaz, F. Martinez, B. Gel, and A. Navarro Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients Eur J Cancer 46 2010 642 649
159. A.V. Salnikov, J. Gladkich, G. Moldenhauer, M. Volm, J. Mattern, and I. Herr CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients Int J Cancer 126 2010 950 958
160. G.V. Glinsky "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management J Clin Oncol 26 2008 2846 2853
161. T. Hu, S. Liu, D.R. Breiter, F. Wang, Y. Tang, and S. Sun Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis Cancer Res 68 2008 6533 6540
162. J.S. You, J.K. Kang, D.W. Seo, J.H. Park, J.W. Park, and J.C. Lee Depletion of embryonic stem cell signature by histone deacetylase inhibitor in NCCIT cells: involvement of Nanog suppression Cancer Res 69 2009 5716 5725